VESIcare is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Solifenacin Succinate.
| Product ID | 68151-5406_7e21fcad-aea8-4621-8391-5e2945b259a4 | 
| NDC | 68151-5406 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | VESIcare | 
| Generic Name | Solifenacin Succinate | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2005-01-05 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA021518 | 
| Labeler Name | Carilion Materials Management | 
| Substance Name | SOLIFENACIN SUCCINATE | 
| Active Ingredient Strength | 5 mg/1 | 
| Pharm Classes | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2018-12-31 | 
| Marketing Start Date | 2017-12-28 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA021518 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2017-12-28 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| SOLIFENACIN SUCCINATE | 5 mg/1 | 
| SPL SET ID: | 100678f1-313a-4e99-ae77-319c610a830f | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 68151-5406 | VESIcare | VESIcare | 
| 70518-1866 | VESIcare | VESIcare | 
| 50090-0972 | VESIcare | VESIcare | 
| 51248-150 | VESIcare | VESIcare | 
| 51248-151 | VESIcare | VESIcare | 
| 55154-3877 | VESIcare | VESIcare | 
| 55154-3878 | VESIcare | VESIcare | 
| 55154-3876 | VESIcare | VESIcare | 
| 55154-3875 | VESIcare | VESIcare | 
| 70518-2094 | VESIcare | VESIcare | 
| 0093-5263 | Solifenacin Succinate | Solifenacin Succinate | 
| 0093-5264 | Solifenacin Succinate | Solifenacin Succinate | 
| 0591-3795 | Solifenacin succinate | solifenacin succinate | 
| 0591-3796 | Solifenacin succinate | solifenacin succinate | 
| 27241-037 | solifenacin succinate | solifenacin succinate | 
| 27241-038 | solifenacin succinate | solifenacin succinate | 
| 29300-328 | Solifenacin Succinate | Solifenacin Succinate | 
| 29300-329 | Solifenacin Succinate | Solifenacin Succinate | 
| 31722-027 | solifenacin succinate | solifenacin succinate | 
| 31722-028 | solifenacin succinate | solifenacin succinate | 
| 35561-286 | Solifenacin Succinate | solifenacin succinate | 
| 42291-740 | Solifenacin Succinate | solifenacin succinate | 
| 46708-192 | Solifenacin Succinate | Solifenacin Succinate | 
| 46708-193 | Solifenacin Succinate | Solifenacin Succinate | 
| 48792-7909 | solifenacin succinate | solifenacin succinate | 
| 48792-7910 | solifenacin succinate | solifenacin succinate | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  VESICARE  88833757  not registered Live/Pending | Astellas Pharma Inc. 2020-03-13 | 
|  VESICARE  75932952  2535639 Live/Registered | ASTELLAS PHARMA INC. 2000-03-02 |